Oncoinvent Announces Changes to its Board of Directors and F

Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced the appointment of newly elected members of its Board of Directors (BOD) and the formation of a Scientific and Clinical...

Related Keywords

Oslo , Norway , London , City Of , United Kingdom , Cambridge , Cambridgeshire , Ingrid Teigland Akay , Gillies Obryan , Hochschule Hannover , Pronova Biopharma , Anne Cecilie Alvik , Hilde Steineger , Clavis Pharmas , Troy Larsen , Strongbridge Biopharma , Bristol Myers Squibb , London Business School , Amgen , Nycomed Imaging Amersham Health Now Ge Healthcare , Fusion Pharmaceuticals , Cranfield School Of Management , Head Of International At Mirati Therapeutics , Linear Energy Transfer , University Of Oslo , Clarity Pharmaceuticals , Takeda Pharmaceuticals , Cubist Pharmaceuticals , University Of Cambridge , Sanofi Aventis , Agios Pharmaceuticals , Announces Changes , Clinical Advisory , Clinical Advisory Board , Chief Executive Officer , Oncoinvent Board , Cranfield School , Teigland Akay , Alex Therapeutics , Neuro Events Labs , Diminished Hochschule Hannover , London Business , Arxx Therapeutics , Spago Nanomedical , Amersham Health , Chief Operating Officer , Nordic Nanovector , Medical Biochemistry , Senior Vice President , Mirati Therapeutics , Pharmaceutical Sciences , Pharmacy Law , Cecilie Alvik ,